Canopy Growth Co. (NASDAQ:CGC - Get Free Report) was the target of some unusual options trading on Tuesday. Stock traders purchased 46,018 call options on the company. This represents an increase of 171% compared to the average volume of 17,008 call options.
Institutional Trading of Canopy Growth
Institutional investors have recently bought and sold shares of the business. CIBC Asset Management Inc bought a new position in shares of Canopy Growth during the 2nd quarter valued at about $91,000. Insigneo Advisory Services LLC bought a new position in Canopy Growth in the second quarter valued at approximately $96,000. Genesee Capital Advisors LLC increased its position in shares of Canopy Growth by 15.3% during the second quarter. Genesee Capital Advisors LLC now owns 15,047 shares of the company's stock worth $97,000 after acquiring an additional 2,000 shares in the last quarter. Vontobel Holding Ltd. acquired a new stake in shares of Canopy Growth during the third quarter worth $92,000. Finally, Stratos Wealth Advisors LLC bought a new stake in Canopy Growth in the 3rd quarter valued at $97,000. Institutional investors and hedge funds own 3.33% of the company's stock.
Canopy Growth Price Performance
Shares of NASDAQ CGC traded up $0.64 during mid-day trading on Tuesday, hitting $4.98. 18,339,556 shares of the stock were exchanged, compared to its average volume of 7,687,481. The company has a market cap of $379.47 million, a P/E ratio of -0.78 and a beta of 0.86. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.64 and a current ratio of 2.15. Canopy Growth has a twelve month low of $2.76 and a twelve month high of $14.92. The stock's fifty day simple moving average is $5.01 and its two-hundred day simple moving average is $6.93.
Canopy Growth (NASDAQ:CGC - Get Free Report) last posted its quarterly earnings data on Friday, August 9th. The company reported ($0.37) earnings per share for the quarter, missing the consensus estimate of ($0.31) by ($0.06). Canopy Growth had a negative net margin of 240.19% and a negative return on equity of 73.30%. The company had revenue of $48.39 million during the quarter, compared to analyst estimates of $51.82 million. As a group, analysts forecast that Canopy Growth will post -1.42 EPS for the current fiscal year.
Analysts Set New Price Targets
Separately, Piper Sandler cut their price objective on Canopy Growth from $3.00 to $2.00 and set an "underweight" rating for the company in a report on Tuesday, July 9th.
Read Our Latest Stock Analysis on CGC
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
See Also
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.